共 429 条
[31]
Golub Sk(2022)Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection HIV Med. 23 e25896-8
[32]
Gamarel KE(2022)Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study J Int AIDS Soc 25 e25974-11
[33]
Rendina HJ(2022)Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study J Int AIDS Soc 25 799-413
[34]
Surace A(2022)Retention in event-driven PrEP among young Thai men who have sex with men at risk of HIV acquisition Int J STD AIDS. 33 1-258
[35]
Lelutiu-Weinberger CL(2022)Risk factors associated with loss to follow-up among transgender women receiving HIV pre-exposure prophylaxis in Chiang Mai province Thailand. AIDS Behav 5 20552076221102770-428
[36]
Wilson EC(2022)Usability and effectiveness of adherence monitoring of a mobile app designed to monitor and improve adherence to event-driven and daily HIV pre-exposure prophylaxis among men who have sex with men in Taiwan Digit Health 22 e37936-e410
[37]
Jalil EM(2022)Effect of a reminder system on pre-exposure prophylaxis adherence in men who have sex with men: prospective cohort study based on WeChat intervention J Med Internet Res 24 239-582
[38]
Castro C(2020)Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial Lancet 396 447-60
[39]
Martinez Fernandez N(2018)Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48-week results of a demonstration study Lancet 62 21-37
[40]
Kamel L(2013)The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men J Acquir Immune Defic Syndr 74 S21-52